Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

Unveiling a new chapter in the understanding of human genetics, scientists have discovered a hidden geometric code within our ...

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need ...

James Dewey Watson, the molecular biologist whose work helped decode the structure of DNA, died on November 6, 2025, at a ...

Around 25 million Americans have a rare genetic disease, and many of them struggle with not only a lack of effective ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such "gene-switch" tools allow scientists to "turn on" ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

Iain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical ...

Mark Zuckerberg and Priscilla Chan today announced the launch of a first-of-its-kind initiative combining frontier artificial intelligence and frontier biology to dramatically accelerate scientific ...